Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 10, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for April 8, 2005 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Beasley Allen Attorney Andy Birchfield Named Co-lead Counsel for Vioxx lawsuits

The multi-district litigation involves the largest drug recall in history.

Montgomery, AL (PRWEB) April 8, 2005 -- Jere Beasley, founding shareholder at the Beasley Allen law firm in Montgomery, Ala., announced in a press conference this afternoon that Andy Birchfield had been named co-lead counsel for the Vioxx multi-district litigation (MDL). Birchfield, the firms lead Vioxx attorney, has been investigating claims against the manufacturer of the arthritis drug since 2000.

andyvioxxcounsel.jpg

In a pretrial order issued today, Judge Fallon of the United States District Court in Louisiana appointed Mr. Birchfield of Beasley Allen as co-lead counsel with regard to pending Vioxx products liability litigation.

Additionally, the Court appointed Andy Birchfield to the Plaintiffs Steering Committee (PSC) Executive Committee. Among the many duties of Executive Committee members, it is their responsibility to coordinate the responsibilities of the PSC and to appear at periodic court announced status conferences. A spot on the committee is coveted because its members navigate issues that can affect the outcome of the cases such as gathering evidence, interviewing witnesses, choosing expert witnesses and developing overall strategy. They also meet with the judge and Merck's lawyers regularly.

The appointment of Mr. Birchfield is significant in regard to all Vioxx lawsuits filed in federal courts because the Multi District Litigation will deal with the largest drug recall in history. Beasley Allen is committed to working on the massive problems caused to hundreds of thousands of people who trusted Merck to put a safe product on the market and who later learned that they had been betrayed," says Birchfield. Vioxx should never have been put on the market and the FDA made a serious mistake when it approved the drug for sale."

Beasley Allen is currently evaluating more than 10,000 Vioxx cases and expects to file hundreds of lawsuits against Merck in the coming months. The first Vioxx case is scheduled to be tried by Beasley Allen on May 23, 2005 in the Circuit or State Court of Clay County in Ashland, Ala. The case number is CV 03-073, Cheryl Rogers V. Merck.

A news article about Birchfields appointment can be found at: http://www.al.com/newsflash/regional/index.ssf?/base/business-1/1112994415191960.xml&storylist=alabamanews

Andy Birchfield is available for commentary and can be reached directly at 800-898-2034 (office) or 334-451-0866 (mobile).

Contact:
Andy Birchfield
http://www.beasleyallen.com
Beasley Allen, Crow, Methvin, Portis & Miles, P.C.
800-898-2034

###

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Andy Birchfield
Beasley Allen
800-898-2034
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright